Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)

Sponsor
Imperial College Healthcare NHS Trust
Study ID
NCT07769138
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Continuous Glucose Monitoring
  • Hyperglycemia
  • Hypoglycaemia
  • Intensive Care (ICU)
  • Type 1 Diabetes
  • Type 2 Diabetes Treated With Insulin

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dexcom G7 — DEVICE
    Continuous glucose monitoring.
  • ViewsEMR telemetry — DEVICE
    ViewsEMR Telemetry is a digital platform used to monitor participants' real-time CGM data and glucose trends

Study Details

The aim of this observational study is to assess safety and implementation of continuous glucose monitors within the Intensive Care Unit. The Dexcom G7 is a continuous glucose monitoring system that shows blood glucose values in real-time and includes alarms if the glucose is very low or high.

Key Dates

First listed
Aug 17, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
70 participants (estimated)

Arms

  • Arm: Adjunctive use of continuous glucose monitoring (Dexcom G7) with telemetry (ViewsEMR/CampViews®)
    Adjunctive use of continuous glucose monitoring (Dexcom G7) with telemetry (ViewsEMR/CampViews®)
  • Arm: Usual care + masked Dexcom G7
    Use of continuous glucose monitoring (Dexcom G7) without telemetry (ViewsEMR/CampViews®)

Primary Outcome Measure

Phase 1: Eligible participants that consent to participate. [ Time Frame: Throughout Phase 1 study period, up to 6 months ]

Central Contacts

Find similar trials

Related Studies